Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
25M
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
6.89K
-
Shares change
-
+6.63K
-
Total reported value, excl. options
-
$29.2K
-
Value change
-
+$28.1K
-
Number of buys
-
7
-
Price
-
$4.24
Significant Holders of TENAX THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (TENX) as of Q1 2024
8 filings reported holding TENX - TENAX THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share as of Q1 2024.
TENAX THERAPEUTICS, INC. - Common Stock, par value $0.0001 per share (TENX) has 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.89K shares
of 25M outstanding shares and own 0.03% of the company stock.
Largest 9 shareholders include Qube Research & Technologies Ltd (4.41K shares), UBS Group AG (1.38K shares), Tower Research Capital LLC (TRC) (537 shares), BlackRock Inc. (300 shares), MORGAN STANLEY (260 shares), WELLS FARGO & COMPANY/MN (2 shares), Allworth Financial LP (1 shares), TUCKER ASSET MANAGEMENT LLC (1 shares), and CIBC Private Wealth Group, LLC (343 shares).
This table shows the top 8 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.